Morgan Stanley sees earnings growth in the pharma sector moderating in FY25–27, though robust balance sheets could support ...

D-Mart said the revenue impact of 100-150 basis points was primarily due to high deflation in staples and non-food products.

Computershare was one of the worst performing ASX 200 stocks in morning trade after Morgan Stanley cut its rating and price ...

In April, private-equity firm New Mountain Capital agreed to sell Real Chemistry for $3 billion after owning the fast-growing ...

It remains unclear whether the 50 per cent levy announced last week will be applied to all copper products, stoking anxiety ...

So you've finally hit that $3 million mark in retirement savings. Maybe you sold a business, maxed out your 401(k) for ...

US stocks have swung from a dramatic April selloff to new heights. Now, traders are about to see if Corporate America’s report cards justify the optimism priced into equity markets. Expectations ...

Arnaud Blanchard, global head of equity capital markets at Morgan Stanley, joins WSJ’s Take On the Week to discuss how recent ...

Investing.com -- Generative AI and diffusion model tools may represent the next major growth catalyst for YouTube and Meta ...

With AI adoption expanding and Azure scaling further, Oppenheimer expects Microsoft to be “one of the long-term AI winners in ...

Street Talk understands Morgan Stanley and Gilbert + Tobin have been appointed to sell Dental Boutique, a chain of general ...

SpaceX is investing $2 billion into xAI, Elon Musk's AI venture, as part of a larger $5 billion fundraising effort. This ...